Call for Abstract

2nd International Conference on Digital Health, will be organized around the theme Redefining Innovation in Healthcare by Modern Technologies

Digital Health 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Digital Health 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Big Data and analytics is an integral part of digital transformation .Many organisations have undergone a digital transformation to adapt the ever-changing digital landscape. They are achieving transformation through their control over Big Data and Analytics, and by using Machine Learning technology. Big data offers organisations the chance to learn more than what has ever been possible about what their customers want. Many health plans still rely on legacy technologies to power their business. This makes them vulnerable to customer-centric, tech-enabled newcomers. But IT leaders have a window of opportunity to unlock system data, enabling care orchestration.

 

Telemedicine is the use of telecommunication and information technologies to provide clinical and medical health care at a distance. It helps to eliminate distance barriers and can improve access to clinical services that would often not be consistently available in distant rural communities. It is also used to save lives in critical care and emergency situations. Although there were distant precursors to telemedicine, it is essentially a product of 20th century telecommunication and information technologies. These technologies permit communications between patient and medical staff with both convenience and loyalty, as well as the transmission of medical, imaging and health informatics data from one site to another. It is a process for accurate data collection in digital format and an electronic medical record for data incorporation .Remote transmission Telemedicine is a system for automatically flagging and providing feedback for outlier data.

 

m-Health is defined as the medical and public health practice supported by mobile devices, such as mobile phones, patient monitoring devices, personal digital assistances and other wireless devices. mHealth is already being used to monitor a variety of conditions including heart disease, diabetes, autism, insomnia and asthma. The   WHO/ITU programme aims to assist governments to use mobile components to reinforce their existing national health activities to prevent, manage, and treat non-communicable diseases (NCDs) and their risk factors

Benefits include:

Global mHealth Market was valued at $10.5 billion in 2014 and is expected to grow at a CAGR of 33.5% during 2015-2020. The mHealth market is in its nascent stage and is expected to yield significant revenues with increasing awareness and favorable regulatory impositions specific to the quality and feasibility of mobile-based medical devices. Penetration of mobile phones in healthcare segment has had a significant impact on the overall healthcare industry.

 

 e- health encompasses much of medical informatics but tends to prioritise the delivery of clinical information, care and services rather than the functions of technologies. Throughout many western national healthcare services, extensive e-Health infrastructures and systems are now viewed as central to the future provision of safe, efficient, high quality, citizen-centred health care. e- Health market growth is attributed to the transition of the healthcare industry into the digital healthcare system for patient’s management and analysis of health. 

The global electronic health (e Health) market is growing at a swift pace and is projected to witness robust growth in the coming years. Technological developments, innovations, and the use of electronic devices are augmenting the global e Health market. The increasing adoption of these systems by medical practitioners across the globe is anticipated to offer promising opportunities for prominent players in the market. Global e Health market is expected to reach USD 308.0 billion by 2022, according to a new report by Grand View Research Inc. The transition of the healthcare industry into digital healthcare system for management and analysis of patient health is expected to be the most vital driver of the market.

 

Nowadays, it goes without saying that the use of information technology is important, even necessary, in the field of life sciences.

The amount of information that needs to be processed, analysed, stored, and represented is constantly growing. These data must then be integrated, compared, and viewed alongside other data to further knowledge and generate added value. Even beyond the issues presented by managing data and the effort required to process this information, the challenge is to improve the capacity of researchers to develop new hypotheses, produce innovative models, and test them.

Bio-Informatics and Information Management professionals are experts in managing the collection, storage, retrieval, analysis and interpretation of health care data and information. To provide the highest quality health care delivery, health care information is used not only for patient care, but also for medical legal issues, reimbursement, research, planning and evaluation.  Opportunities for employment are found in a variety of settings, including hospitals, clinics, rehabilitation centers, home health agencieshealth maintenance organizations, insurance agencies, governmental agencies, educational institutions and research centers.

 

Due to advancement of healthcare technologies, a number of start-up Companies utilises digital and Internet-based health technologies to make behavioural and lifestyle changes in patients. A number of start-up Companies based on Digital Health Therapeuticstelehealth, Digital Pathology, Digital health, e HealthmHealth Companies are being promoted with their latest innovative methodologiesthat uses digital implements like mobile-devices, apps, sensors, etc to spur behavioural changes in patients.

Market Analysis

In 2016, the global digital health market was at $179.6 billion, according to Transparency Market Research (TMR). Growth in this market is anticipated to rise at a CAGR of 13.4% between 2017 and 2025, reaching $536.6 billion by the end of 2025. Over the next few years, TMR says the market will be supported by technology advancements in the medical and healthcare infrastructure.

 

Clinical Trial is a part of clinical research that follows a regulated protocol or a plan of action. They are primarily performed to get data on safety and efficacy of the new developed drug , this data is mandatory for  further approval of the drug and to bring it to the market.

The clinical trials market has been estimated to reach USD 14.2 billion in 2016 and is projected to reach around USD 22 billion by the year 2021, growing at a CAGR (compounded annual growth rate) of 7.5%, during the forecast period 2016 to 2021. Key drivers impacting the market growth are globalization of clinical trials, development of new treatments such as personalized medicine, augmenting evolution in technology, and boosting demand for CROs to conduct clinical trials. Clinical studies can be sponsored, or funded, by pharmaceutical companies, academic medical centers, voluntary groups, and other organizations, in addition to Federal agencies such as the National Institutes of Health, the U.S. Department of Defense, and the U.S. Department of Veterans Affairs. Doctors, other health care providers, and other individuals can also sponsor clinical research.

 

Precision medicine makes use of variations in consumers genes, environment, and lifestyle to guide the prevention, diagnosis, and treatment of diseases. The potential for precision medicine to radically transform the healthcare industry is driving interest among a range of companies and government organizations. . Firms are flocking to develop the tools needed to extract, store, share, and analyze genomic data. The global precision medicine market is expected to grow at an annualized rate of 12% over 7 years to reach $88.6 billion by 2022, up from $39 billion in 2015, according to Market Research Future.